HSBC Holdings’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
VPM
QCM
VCM
NAMA
HSBC Holdings's TXG Position: Q1 2026 in Review
HSBC Holdings opened a new position in 10x Genomics (TXG) in Q1 2026: 285,389 shares worth $5.94M. The stake represents ﹤0.01% of the portfolio and ranks #1110 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in TXG as recently as Q3 2025.
HSBC Holdings first reported a position in TXG in Q4 2020 and has held it in 15 quarters since. The position peaked at $9.47M in Q1 2021. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.
- HSBC Holdings held 285,389 shares of 10x Genomics worth $5.94M as of Q1 2026.
- 10x Genomics was a new HSBC Holdings position in Q1 2026.
- 10x Genomics made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1110 holding.
- HSBC Holdings first reported a position in 10x Genomics in Q4 2020 and has held it in 15 quarters since.
- HSBC Holdings's 10x Genomics position peaked at $9.47M in Q1 2021.
- 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.